Escolar Documentos
Profissional Documentos
Cultura Documentos
doi:10.1016/S1473-3099(14)70728-5
and molluscum should publish the results showing lack of efficacy. Most importantly, physicians should stop recommending and prescribing imiquimod to treat molluscum contagiosum in children. I am a shareholder in Synta Pharmaceuticals Corp and Arrowhead Research Co. The views presented in this Correspondence are those of the author and do not necessarily represent the views of The Permanente Medical Group.
References
1 Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis 2013; 13: 877-888. Summary | Full Text| PDF(2894KB) | PubMed 2 DailyMed. Aldara (imiquimod) cream for topical use. Revised 4/2007. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fccca4e-fb8f-42b8-95558f78a5804ed3. (accessed April 1, 2014). 3 Katz KA, Swetman GL. Imiquimod, molluscum, and the need for a better Best Pharmaceuticals for Children. Pediatrics 2013;132: 1-3. PubMed 4 Benjamin DK, Smith PB, Murphy MD, et al. Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA2006; 296: 1266-1273. PubMed 5 van der Wouden JC, van der Sande R, van Suijlekom-Smit LW, et al. Interventions for cutaneous molluscum contagiosum.Cochrane Database Syst Rev 2009; 4. CD004767